Recent Quotes (30 days)

You have no recent quotes
chg | %

Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for elite
0.225
-0.003 (-1.32%)
Sep 4 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.22 - 0.24
52 week 0.17 - 0.39
Open 0.23
Vol / Avg. 1.04M/663,342.00
Mkt cap 148.71M
P/E 3.60
Div/yield     -
EPS 0.06
Shares 660.92M
Beta 0.20
Inst. own 0%
Sep 9, 2015
Elite Pharmaceuticals Inc at Rodman & Renshaw Global Investment Conference - 2:10PM EDT - Add to calendar
Jun 16, 2015
Full Year 2015 Elite Pharmaceuticals Inc Earnings Call
Jun 15, 2015
Full Year 2015 Elite Pharmaceuticals Inc Earnings Release
  

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 227.09% 576.83%
Operating margin 35.46% -329.14%
EBITD margin - -316.83%
Return on average assets 231.00% 115.17%
Return on average equity - -
Employees 36 -
CDP Score - -

Address

165 Ludlow Ave
NORTHVALE, NJ 07647-2305
United States - Map
+1-201-7502646 (Phone)
+1-302-6745266 (Fax)

Website links

Description

Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company owns, licenses or contract manufactures various products, including phentermine hydrochloric acid (HCl) 37.5 milligram tablets for bariatric, methadone HCl 10 milligram tablets and hydromorphone HCl 8 milligram tablets for pain, phendimetrazine tartrate 35 milligram tablets for bariatric, phentermine HCl 15 milligram and 30 milligram capsules for bariatric, naltrexone HCl 50 milligram tablets for pain, isradipine 2.5 milligram and 5 milligram capsules for cardiovascular diseases, and hydroxyzine HCl 10 milligram, 25 milligram and 50 milligram tablets, which are antihistamines. The Company also owns ELI-200, an undisclosed opioid with sequestered naltrexone capsules. The Company's Northvale Facility operates under current good manufacturing practice (cGMP).

Officers and directors

Jerry I. Treppel Chairman of the Board
Age: 60
Nasrat Hakim President, Chief Executive Officer, Director
Age: 54
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 51
Douglas Plassche Executive Vice President - Operations
Age: 51
Jeenarine Narine Director
Age: 65
Barry H. Dash Ph.D. Independent Director
Age: 84
Jeffrey A. Whitnell CPA Independent Director
Age: 59